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Streptococcus-related glomerulonephritis
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A vast array of experimental, pathological and immuno-
logical data on human glomerulonephritis leads to the con-
clusion that the disease process is primarily immunologic in
nature [1]. However, with few exceptions, our knowledge
of the involved antigens and the mechanisms of injury is
still quite nebulous. This is particularly true of strepto-
coccus-related glomerulonephritis. In this review we will
examine the evidence for a role for the streptococcus in
human glomerulonephritis. Our discussion will be divided
into two sections, as the pathological processes in the acute
and the chronic progressive forms of the disease appear to
be dissimilar.
Acute poststreptococcal glomerulonephritis
There is abundant epidemiological evidence that infec-
tion with certain streptococcal strains is associated with
outbreaks of acute glomerulonephritis, but the mechanism
or mechanisms whereby such infection leads to the develop-
ment of renal lesions is unclear. Immune complexes formed
with streptococcal antigens may well play a key role in the
pathogenesis of this disorder.
Judging from biopsy evidence, immune complexes of
some kind are involved in most cases of acute glomerulo-
nephritis. Deposits of both gamma globulin and of the fl1C
component of complement are found in the glomeruli of a
large majority of the renal biopsy specimens from patients
with this disease [2—8] (see Table 1). While the relative
amounts of these two proteins vary considerably from spe-
cimen to specimen in these reports, they were usually seen
in association with each other. However, fl1C was occasion-
ally found in the mesangial areas, whereas gamma globulin
was rarely, if ever, found in these areas. When looked for,
increased amounts of fibrin were also detected in the gb-
meruli, most often within and between the proliferating
cells, but not near the granular deposits of gamma globulin
and fl1C along the basement membrane. Fig. I shows an
example of the distribution of gamma globulin deposits in
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Table 1. Summary of results from studies of renal biopsy speci-
mens from patients with acute glomerulonephritis using fluores-
cein-labeled antisera
Antiserum
to:
McCluskey
et al
[21
Feldman
et al
[41
Seegal
et al
[5]
Michael
et al
[3]
Treser
et al
[8]
Gamma
globulin 12/17 9/9 10/12 12/16 35/35
fl1C 12/17 9/9 11/12 13/16 34/35
Fibrinogen/
fibrinogen
products 12/17 7/8 NT 5/10 NT
Albumin 0/17 NT 0/12 0/8 0/35
Streptococcal
antigens 0/17 0/9 7/12 3/10 12/35
Numerator: number of positive specimens; denominator: num-
ber of biopsies studied.
NT= not tested.
Fig. 1. Glomerulus of patient with early well-documented acute
post streptococcal glomerulonephritis stained with fluorescein-
labeled antihuman gamma globulin (x 800, approx.).
the glomerulus of a patient with early, well-documented
poststreptococcal gbomerulonephritis.
However, in a minority of patients, especially in those
seen and biopsied early during an outbreak of M-Type 49
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Fig. 2. Glomerulus of patient with early well-documented acute
post streptococcal glomerulonephr it is stained with fluorescein-
labeled antiserum to M-Type 12 whole streptococcus (x 1000,
approx.).
infections described by Fish et al [7], there were only
"interrupted linear deposits of 111C" along the glomerular
basement membrane, in the absence of any gamma globulin.
The authors suggest that their findings may reflect a direct
toxic effect on the glomerular basement membrane by
some factor involved in the infection.
Are streptococcal antigens found in the diseased glome-
rulus? At least three investigators have found them in renal
biopsy material: Seegal et al [5] in seven out of 12 biopsies,
Michael et al [3] in three out of ten and finally Treser and
Lange [8] in 12 out of 35 cases. All these investigators
found, however, that the deposits of streptococcal antigens
were not present along the basement membrane where one
finds deposits of fixed gamma globulin. Instead, these de-
posits were primarily in the mesangium, in between and even
seemingly within the cytoplasm of the proliferating endo-
thelial cells. Figure 2 shows a diseased glomerulus from a
patient with well-documented, poststreptococcal glomeru-
lonephritis stained with fluorescein-labeled antiserum to
M-Type 12. The characteristic deposits of streptococcal
antigen are seen to reside primarily in the mesangial area
of the glomerulus.
The failure of other investigators to confirm the obser-
vations that streptococcal antigens are present in the gb-
meruli of patients with poststreptococcal glomerulonephri-
tis and the unusual distribution of these antigens when
found appear at first to be paradoxical. There are two
possible explanations for these discrepancies.
In the first place, the finding of streptococcal antigens
may be a matter of timing. In the studies of Michael et al
[3], positive results usually were obtained in biopsies se-
cured during the first week after onset of clinical symptoms.
Negative results were more likely to occur when biopsies
were obtained two or more weeks following onset of the
disease. Even the more severely affected patients studied by
Seegal et al [5] no longer showed positive staining for
streptococcal antigens on second biopsy, suggesting that
either destruction or, more likely, masking of the antigen
by antibody had occured in these cases.
Evidence from both human lupus nephritis and from
experimentally induced nephritis would point to the possi-
bility of antigen-masking by antibody as an explanation for
the "disappearance" of streptococcal antigens from the
glomerulus with time, and for their apparent absence in the
nodular deposits. Koffler et al [9] were able to demonstrate
that large deposits of DNA antigen were present in the
nodular deposits in glomeruli from patients with lupus
nephritis only after salt-elution of the antiDNA antibody
from the biopsy specimen. In the same way Edgington,
Glassock and Dixon [10] were able to demonstrate the
presence of antigen in the glomeruli of animals with experi-
mentally induced autoimmune nephritis only after elution
of the antibody from these glomeruli. To our knowledge,
this type of elution study has not as yet been performed in
acute glomerulonephritis.
The second explanation may lie in the nature of the anti-
serum used. For example, the studies of Feldman, Mardiney
and Shuler [4] were carried out with antisera which had not
been previously tested for their capacity to bind specific
streptococcal antigens. The antisera are usually made in
rabbits and, as Rotta et al [11] have demonstrated, rabbits
can differ markedly in their ability to make antibodies to
different streptococcal structures.
There is considerable disagreement as to the exact nature
of the streptococcal antigen present in the human renal
biopsies. Treser et al [12], using fluorescein-labeled antisera
to purified streptococcal membranes, state that the antigen
is a part of the membrane structure of the streptococcal
cell. In contrast, using antisera prepared against membranes
obtained from four different M-type streptococcal strains,
including the Type 12 strain mentioned above, we failed to
localize streptococcal membrane antigens in patients who
exhibited positive staining with antiserum prepared against
whole Type 12 organisms. In addition, adsorption studies
with Type 12 cell walls and purified membranes (less than
0.01 % rhamnose and less than 2 % muramic acid) revealed
that the adsorption of immunofluorescent staining was
achieved only with the cell wall preparations. This ability
to abolish the immunofluorescent staining was destroyed
by treating the cell wall preparations with either trypsin or
hot HCI, suggesting that M protein, which is destroyed by
these extractions, might be the antigen involved.
Experimental evidence also points to the possibility that
either M protein or an M-associated protein may be a
significant antigen. This may also account for the localiza-
tion of streptococcal antigen in the mesangium where fibrin
but not gamma globulin is found, and also for the fact that
the nephritogenicity of a given strain of streptococcus
seems to be associated with its M-type. Kantor [13, 14]
demonstrated that acid-extracted Type 1 M protein, which
complexes with fibrinogen, localizes in the glomerular ca-
pillaries and in between what appears to be the epithelial
cells of the glomerular tufts. Following this lead, Humair,
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Fig. 3. Radial diffusion plate containing 10 mg/mI humanfibrinogen
in agar; diminishing concentrations of Type 12 M protein extract
in wells. Note diminishing diameter of precipitation ring as
concentration of M protein decreases.
Briggs, and co-workers [15—17] were able to induce a mild,
self-limited glomerulonephritis in mice using repeated in-
jections of acid-extracted M protein alone, or of soluble
complexes of this M protein and its antibody. Both M
protein and fibrinogen were then found in the mesangial
cells. Urokinase and "plasminogen activator," which deplete
the animal's store of fibrinogen, prevented cellular proli-
feration and the development of nephritis in the animals,
possibly by preventing the formation of fibrinogen—M
protein complexes. In our laboratory we are developing
evidence that the affinity of M protein or M-associated
protein for fibrinogen varies with the M-type. By incorpo-
rating 5 or 10 mg/ml human or bovine fibrinogen into agar,
a radial diffusion plate can be made (Fig. 3). The zone of
precipitation which develops between M protein extract
placed in a well in the agar and the fibrinogen in the agar
varies with the M-type of the extract used as well as with
the concentration of that extract. This usique affinity of
certain M-protein substances for fibrinogen may be im-
portant in the "nephritogenicity" of a given strain.
In order to tie together the facts and speculations dis-
cussed above, we would like to present a scheme for the
pathogenesis of acute poststreptococcal glomerulonephritis,
as diagrammed in Fig. 4. Following a streptococcal in-
fection the patient could have either a toxic reaction to a
streptococcal product, or deposition of antigen-antibody
complexes or of fibrinogen—M protein complexes in the
kidney, or a combination of these events. In the presence of
fibrinogen there is mesangial cell proliferation, but as there
is no common antigen recognized between the streptococcal
products and autologous antigens, the host eventually clears
the offending complexes from the kidney and the disease is
self-limited. While a number of these steps are speculative,
they are at least open to experimental testing. We would like
to suggest the following methods of approach as being of
immediate value: 1) examination of early kidney biopsies in
patients with acute poststreptococcal glomerulonephritis;
2) a search for extracellular streptococcal toxins which by
binding to glomerular structures may cause the initial insult
to glomerular tissues; 3) antibody elution techniques to
expose possible antigen(s) present but obscured by anti-
body; 4) use of antisera to more highly purified streptococcal
antigens in order to demonstrate the precise nature of the
antigen(s) present; 5) use of immunofluorescent techniques
and electron microscopy methods to evaluate coupling of
the streptococcal antigen(s) with fibrinogen and the locali-
zation and fate of such complexes.
Chrome progressive glomerulonephritis
It is clear that infection with group A streptococci can
result in acute glomerulonephritis. Can we implicate this
organism in the pathogenesis of chronic progressive gb-
merulonephritis?
The clinical evidence for this implication is controversial.
Most large-scale follow-up studies have failed to show an
increased incidence of chronic nephritis in patients following
an attack of acute poststreptococcal glomerulonephritis
[18, 19]. Other studies have shown on-going nephritis in
a significant number of patients [20]. Earle and Jennings
[21] studied a group of 35 patients with clinical and biopsy
evidence of chronic progressive glomerulonephritis. Two-
thirds of these patients had a history of acute nephritisat the
onset of their disease. One-third of them had serum anti-
bodies to Type 12 streptococci, in contrast with a control
population of normals and patients with other renal disease,
among whom only 10 to 12% were positive for these anti-
bodies. These type-specific antibodies are persistent and
protective against further infection by the same nephrito-
genic type [22].
In one study [23], 20 out of 28 exacerbations of chronic
glomerulonephritis in patients were associated with well-
documented group A streptococcal infections. Only eight
nonstreptococcal infections out of a total of 282 in 68 pa-
tients resulted in exacerbations. No M-typing of the strep-
tococci was performed. If type-specific antibodies are
protective and persistent, we must assume that the repeated
infections in these 13 patients were due to streptococci with
Streplococcal Infection
Throat
Skin — Streplococcal Antigen Release
Fibrinogen Complex
Extracellular Toxins Release STREPTOCOCCAL (?MProteifl)
ANTIGEN
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Fig. 4. Proposed pathway of pathological damage in acute post-
streptococcal glomerulonephritis. Dotted lines represent possible
alternate pathway.
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different M-types. Thus, if we wanted to implicate a strep-
tococcal antigen in the pathogenesis of these exacerbations,
it would have to be an antigen common to all M-types. The
most likely candidate would be a streptococcal membrane
antigen.
Several investigators have provided evidence suggesting
that cellular sensitivity to streptococcal membrane is
present in patients with chronic progressive glomerulo-
nephritis. The techniques used have included the direct
migration inhibition method [24—26] and the lymphocyte
transformation method as measured by thymidine-2-14C
incorporation [24]. Patients with clinical and biopsy evi-
dence of chronic progressive glomerulonephritis showed
markedly greater cellular reactivity to streptococcal mem-
branes, irrespective of M-type, than patients with other
renal diseases or normal controls. To test whether or not
patients with chronic progressive glomerulonephritis had
specific cellular reactivity to streptococcal antigens and not
an intrinsic abnormality in cellular responsiveness, reac-
tivity to phytohemagglutinin (PHA) and to BCG was com-
pared in patient and control groups and found to be iden-
tical in both groups.
The work of Macanovic, Evans and Peters [26] also
suggests that cellular sensitization may be the major factor
in the initiation of events in chronic glomerulonephritis.
For example, some patients with cellular reactivity to
streptococcal and to glomerular basement membrane
antigens showed no humoral antibodies to these antigens.
Experimental support for the hypothesis that cells alone
may be involved in the pathogenesis of chronic forms of
glomerulonephritis is provided by the work of Heymann
et al [27] and Hess, Ashworth and Ziff [28], who inde-
pendently were able to transfer Heymann-type autoimmune
nephrosis by cells alone.
How might we link these findings to an overall scheme for
the pathogenesis of some forms of chronic progressive gb-
merulonephritis? In Fig. 5 we have outlined a possible
pathway. In a susceptible individual, sensitization to strep-
tococcal membrane components through repeated strepto-
coccal infections may lead to autosensitization to glomeru-
lar basement membrane components. Streptococcal mem-
brane antigens are serologically cross-reactive with glome-
rular basement membrane components [29, 30]. That there
may also be cellular cross-reactivity is suggested in the
work of Dardenne, Zabriskie and Bach [25] and Macanovic
et al [26]; patients with chronic progressive glomerubone-
phritis exhibiting cellular sensitization to streptococcal
antigens also show cellular sensitization to glomerular base-
ment membrane. Once sensitization to autologous products
is achieved, the process can be self-perpetuating, resulting
in progressive deterioration of renal function. Intercurrent
streptococcal infection could then enhance the already
developing process. This scheme depends on the hypothesis
that the cross-reactivity between streptococcal components
and glomerular basement membrane is more than an in-
cidental finding in chronic progressive glomerulonephritis.
Repeated Streptococcal Infections
Intercurrent Infections
0
Release Streptococcal Membrane Fragments (SM)
Antigen —Antibody Complexes
Release renal membrane
fragments (RM)
"Autoimmune" Nephritis
Fig. 5. Proposed pathway of pathological damage in progressive
glomerulonep hr it is.
This point, as well as other questions raised by the scheme,
is open to experimental and clinical investigation.
The relationship of the streptococcus to renal disease
seems to be an intimate one. The exact nature of this re-
lationship has given rise to much speculation. In this paper
we have presented only some of the possible mechanisms
by which the streptococcus may interact immunologically
with its host, and suggested some approaches for further
investigation.
Reprint requests to Dr. John B. Zabriskie, Rockefeller Univer-
sity, 66th Street and York Avenue, New York, N. Y. 10021
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